Divyalakshmi Ramakrishna, MDS
Content writer – Clinical
Divyalakshmi is a Clinical Content Writer at Rhenix. She is responsible for writing scientific content on healthcare-related topics. She also focuses on writing scientific white papers and review articles focusing on various fields of medicine and healthcare with the main focus on oncology, neurology, and immunology.
​
Divyalakshmi has a Master’s degree in Dental Surgery (MDS) from the Rajiv Gandhi Institute of Health Sciences. Before joining Rhenix, she also worked as Associate Professor at D. A. Pandu Memorial R.V. Dental College and Hospital, Bangalore, India.
​
At Rhenix, she has attained operational as well as scientific writing experiences.
Stories
Summary "Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma."
Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain cancer in adults. It accounts for about 60-70% of gliomas. The standard treatment regimen for GBM is tumor resection followed...
Summary "Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s disease."
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which the death of brain cells causes memory loss and cognitive decline. Alzheimer's disease is the most common cause of dementia...
Summary "Prognostic factors associated with survival in patients with diffuse astrocytoma."
Astrocytomas are the most common primary tumors in the central nervous system (CNS). These tumors arise from astrocytes—star-shaped cells that make up the “glue-like” or supportive tissue of the brain. The diagnosis is based...
Videos
Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma | CellTalk
Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain cancer in adults. It accounts for about 60-70% of gliomas. The standard treatment regimen for GBM is tumor resection followed by radiotherapy and...
Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s disease | CellTalk
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder in which the death of brain cells causes memory loss and cognitive decline. Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral...
Prognostic factors associated with survival in patients with diffuse astrocytoma | CellTalk
Astrocytomas are the most common primary tumors in the central nervous system (CNS). These tumors arise from astrocytes—star-shaped cells that make up the “glue-like” or supportive tissue of the brain. The diagnosis is based primarily on histopathological...
A molecularly integrated grade for meningioma | CellTalk
Meningiomas are one of the most common primary intracranial tumors in adults. As there is a presence of more number of cases worldwide, there is a need for a reliable, widely accessible, and acceptable predictor of clinical outcome after a...
